Kankere ea matšoafo e ntse e le phephetso ea bophelo bo botle lefatšeng ka bophara, e beoa e le mofetše oa bobeli o fumanoang hangata. Ka 2020 feela, ho bile le linyeoe tse ncha tse fetang limilione tse 2.2 lefatšeng ka bophara. Kankere e seng e nyane ea lisele tsa matšoafo (NSCLC) e emela ho feta 80% ea litlhahlobo tsohle tsa mofetše oa matšoafo, e totobatsang tlhoko e potlakileng ea maano a kalafo a reriloeng le a sebetsang.
Liphetoho tsa EGFR li hlahile e le motheo oa phekolo ea motho ka mong ea NSCLC. EGFR tyrosine kinase inhibitors (TKIs) e fana ka mokhoa oa phetoho ka ho thibela matšoao a khannang mofets'e, ho thibela kholo ea hlahala, le ho khothaletsa lefu la lisele tsa mofets'e-kaofela ho fokotsa tšenyo ea lisele tse phetseng hantle.
Litaelo tse ka sehloohong tsa kliniki, ho kenyeletsa le NCCN, hona joale li laela tlhahlobo ea phetoho ea EGFR pele e qala phekolo ea TKI, ho netefatsa hore bakuli ba nepahetseng ba fumana meriana e nepahetseng ho tloha qalong.
Liphetoho tsa EGFR li hlahile e le motheo oa phekolo ea motho ka mong ea NSCLC. EGFR tyrosine kinase inhibitors (TKIs) e fana ka mokhoa oa phetoho ka ho thibela matšoao a khannang mofets'e, ho thibela kholo ea hlahala, le ho khothaletsa lefu la lisele tsa mofets'e-kaofela ho fokotsa tšenyo ea lisele tse phetseng hantle.
Litaelo tse ka sehloohong tsa kliniki, ho kenyeletsa le NCCN, hona joale li laela tlhahlobo ea phetoho ea EGFR pele e qala phekolo ea TKI, ho netefatsa hore bakuli ba nepahetseng ba fumana meriana e nepahetseng ho tloha qalong.
Re Tsebisa Human EGFR Gene 29 Mutations Detection Kit (Fluorescence PCR)
Ho Khetholla ka nepo bakeng sa Liqeto tsa Kalafo ka Botšepehi
Setsi sa ho lemoha sa EGFR sa Macro & Micro-Test se thusa ho tsebahatsa ka potlako le ka nepo liphetoho tsa bohlokoa tse 29 ho li-exons 18–21 ho li-biopsies tsa mokelikeli le tsa mokelikeli—ho matlafatsa baoki hore ba lokise phekolo ka kholiseho.
Ke Hobane'ng ha U Khetha?Macro & Micro-Test'sEGFR Testing Kit?
Kit e lemoha liphetoho tse 29 tse tloaelehileng tsa liphatsa tsa lefutso tsa EGFR ho li-exons 18-21 ho tloha liseleng kapa lisampole tsa mali tsa bakuli ba NSCLC, tse koahelang maikutlo a lithethefatsi le libaka tsa ho hanyetsa ho tataisa tšebeliso ea lithethefatsi tse lebisitsoeng tse kang gefitinib le osimertinib.
- 1.Theknoloji e ntlafetseng ea ARMS: ARMS e ntlafetseng e nang le patented enhancer bakeng sa lintlha tse phahameng;
- 2.Enzymatic Enrichment: E fokotsa semelo sa mofuta o hlaha ka tšilo ea enzymatic, ho ntlafatsa ho nepahala ha ho lemoha le ho fokotsa matlafatso e sa khetheheng ka lebaka la semelo se phahameng sa genomic;
- 3.Ho thibela Mocheso: Ho eketsa mekhahlelo e itseng ea mocheso ts'ebetsong ea PCR, ho fokotsa ho se lumellane le ho eketsa ho nepahala ha ho lemoha;
- 4.High Sensitivity: E lemoha liphetoho tse fetohang ka tlase ho 1% phetoho;
- 5.Ho nepahala ho hoholo: Taolo ea ka hare le enzyme ea UNG ho fokotsa liphello tsa bohata;
- 6.Katleho: Liphetho tsa sepheo nakong ea 120 min
- 7.Dual Sample Support - E ntlafalitsoe bakeng sa lisampole tsa lisele le mali, e fanang ka maemo a feto-fetohang mosebetsing oa bongaka.
- Tšebelisano ea 8.Wide: E lumellana haholo le lisebelisoa tse tloaelehileng tsa PCR 'marakeng;
- 9.Shelf-bophelo: Likhoeli tse 12.
Tataiso ea Phekolo ka Tšepo
Thepa e thusa ho eketsa liphello tsa kliniki le ho lula pele ho khanyetso ka maikutlo a bohlokoa le liphetoho tsa ho hanyetsa.
Eketsa Potefolio ea Hau ea Oncology e nepahetseng
Lekola mefuta ea rona e felletseng ea litharollo tsa ho lemoha phetoho bakeng sa KRAS, BRAF, ROS1, ALK, BCR-ABL, TEL-AML1, le tse ling-tsohle li etselitsoe ho ts'ehetsa tlhokomelo e felletseng e tsamaisoang ke biomarker.
Ithute haholoanyane:https://www.mmtest.com/oncology/
Contact our team: marketing@mmtest.com
Nako ea poso: Sep-23-2025